Neuren Pharmaceuticals Health Care
Biotech Healthcare Pharmaceuticals

$12.25 -0.23 (-1.84%)

High $12.50	Low $12.07	Trades 2,722	Turnover $3,205,258	Volume 261,029
30 June 2023 at 4:55pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code NEU	Name Neuren Pharmaceuticals Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Pharmaceuticals	GIC Sub Industry Pharmaceuticals
Sector Healthcare	IPO Date 2005-02-03	Fiscal Year December	Type Common Stock
Shares Outstanding 126,773,976	Shares Floated 109,742,014	Held by Insiders 13.343%	Held by Institutions 23.522%

Directors & Officers

Name & Education	Position
Mr. Jonathan Charles Pilcher A.C.A., B.Sc., BSc (Hons), F.C.A.	CEO, MD & Executive Director
Ms. Lauren Frazer C.A.	CFO & Company Secretary
Dr. Clive Blower BSc (Hons), Ph.D.	Chief Operations Officer
Mr. Lawrence Glass BA (Biology)	Chief Science Officer
Mr. Gerry Zhao	Chief Business Officer
Dr. Liza A. Squires M.D.	Chief Medical Officer
Mr. Daryl Dekarske M.P.H.	Chief Regulatory Officer

NEU Historic Dividends

Date	Amount
We found no dividends on record for NEU.

End of Day Prices

Date	Close	Volume	Change
31-Jul	$18.00	650,025	+0.52 (2.97%)
30-Jul	$17.48	548,586	+0.35 (2.04%)
29-Jul	$17.13	379,864	+0.08 (0.47%)
28-Jul	$17.05	278,173	+0.35 (2.10%)
27-Jul	$16.70	311,363	+0.24 (1.46%)
24-Jul	$16.46	332,782	0.00 (0.00%)
23-Jul	$16.46	482,913	-0.83 (4.80%)
22-Jul	$17.29	398,049	+0.53 (3.16%)
21-Jul	$16.76	509,283	-0.19 (1.12%)
20-Jul	$16.95	225,770	-0.02 (0.12%)
17-Jul	$16.97	209,662	-3.17 (15.74%)
18-Sep	$20.14	996,599	+0.87 (4.51%)
12-Sep	$19.27	721,746	+0.67 (3.60%)
11-Sep	$18.60	1,200,631	-1.88 (9.18%)
05-Sep	$20.48	718,139	+0.50 (2.50%)
9 up, 5 down, and 1 flat days

Market Cap (31-Jul) $2,281,931,520	EBITDA $22,062,000	PE 71.94	Book Value $2.67
Dividend per Share N/A	Dividend Yield N/A	EPS $0.23	Profit Margin 47.08%
Operating Margin 30.63%	ROA 3.66%	ROE 8.67%	Revenue (FY) $64,649,000
Revenue per Share $0.50	Gross Profit (FY) $28,257,000	Q' YOY Revenue Growth 80.9%	Q' YOY Earnings Growth 88.7%

Neuren Pharmaceuticals Health Care
Biotech Healthcare Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

NEU Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Neuren Pharmaceuticals Health Care Biotech Healthcare Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

NEU Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Neuren Pharmaceuticals Health Care
Biotech Healthcare Pharmaceuticals